StockData
MediWound Ltd. logo

MediWound Ltd. (MDWD) stock

MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$13.68+0.13 (+0.96%)

Close on Nov 17, 2026Market cap $175.58MP/E –Yield –

MediWound gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 19.2%, against 13.0% the year before. The highest annual figure on record is 62.7% in fiscal 2019.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202519.2%+6.2
FY2024Dec 31, 202413.0%−6.1
FY2023Dec 31, 202319.1%−30.5
FY2022Dec 31, 202249.7%+12.8
FY2021Dec 31, 202136.9%+2.2
FY2020Dec 31, 202034.7%−28.1
FY2019Dec 31, 201962.7%+24.1
FY2018Dec 31, 201838.6%+1.8
FY2017Dec 31, 201736.8%+75.3
FY2016Dec 31, 2016-38.5%+280.6
FY2015Dec 31, 2015-319.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202610.9%−12.9
Q2 FY2025Jun 30, 202523.5%−15.5
Q2 FY2024Jun 30, 20248.8%−21.4
Q2 FY2023Jun 30, 202323.8%−59.4
Q2 FY2022Jun 30, 202223.8%−15.1
Q2 FY2021Jun 30, 202139.0%+9.4
Q2 FY2020Jun 30, 202030.2%–
Q2 FY2019Jun 30, 201983.2%–
Q2 FY2018Jun 30, 201839.0%–
Q2 FY2017Jun 30, 201729.5%–

More MediWound figures

See a number that looks wrong?